ESH 2024丨2场Late Breakers日程公布，精彩内容抢先看，敬请期待！

第33届欧洲高血压学会年会（ESH 2024）将于2024年5月31日至6月3日在德国柏林的埃斯特雷尔会议中心举行。此次会议将以线上和线下相结合的新形式呈现，会议类型将更加精简，目的是通过增加教师和观众的互动参与，使会议内容更加丰富。在为期四天的会议中，将有两场Late Breakers，共有12项研究。

以下是两场Late Breakers的研究内容：

LATE BREAKER 1：
- 北京时间：6月2日20:15-21:15

1. 研究名称：STOPPING ANTIHYPERTENSIVE TREATMENT AMONG HYPERTENSIVE PATIENTS IN PRIMARY CARE: THE STOP-TRIAL
高血压患者在初级保健中停止降压治疗：STOP研究

2. 研究名称：EFFECT OF RENAL DENERVATION ON BLOOD PRESSURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND UNCONTROLLED HYPERTENSION: RESULTS OF A PROSPECTIVE RANDOMIZED SHAM-CONTROLLED STUDY
RDN对慢性肾脏疾病合并未控制高血压患者血压的影响：一项前瞻性随机假手术对照研究的结果

3. 研究名称：ASSOCIATION OF CLINIC AND AMBULATORY BLOOD PRESSURE WITH MORTALITY IN PATIENTS WITH AND WITHOUT DIABETES
糖尿病和非糖尿病患者的临床和动态血压与死亡率的关系

4. 研究名称：EFFICACY AND SAFETY OF SACUBITRIL/ALLISARTAN FOR THE TREATMENT OF PRIMARY HYPERTENSION: A PHASE 3 RANDOMIZED, DOUBLE-BLIND STUDY
沙库巴曲/缬沙坦治疗原发性高血压的疗效和安全性：一项3期随机双盲研究

5. 研究名称：HIGHER INCIDENCE OF CARDIOVASCULAR EVENTS IN A LARGE REAL-WORLD DATABASE IN THE TRIENNIUM 2020-2022 COMPARED TO A PRE-COVID TRIENNIUM IS INDEPENDENT OF CARDIOVASCULAR RISK FACTORS
与新冠肺炎之前的三年期相比，2020-2022年三年期大型真实世界数据库中心血管事件的发生率更高，且独立于心血管风险因素

6. 研究名称：MANAGEMENT OF HYPERTENSION IN THE EARLY POSTPARTUM: A RANDOMIZED CONTROLLED TRIAL
产后早期高血压的管理：一项随机对照试验

LATE BREAKER 2：
- 北京时间：6月3日14:30-15:30

1. 研究名称：EFFECT OF DASH VS. MEDITERRANEAN DIET ON METABOLIC SYNDROME PREVALENCE IN ADULTS WITH HIGH NORMAL BLOOD PRESSURE OR GRADE 1 HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL
DASH与地中海饮食对成年高血压或1级高血压患者代谢综合征患病率的影响：一项随机对照试验

2. 研究名称：PEAK NOCTURNAL HOME BLOOD PRESSURE AS AN EARLY AND STRONG NOVEL RISK FACTOR FOR STROKE: THE PRACTITIONER-BASED NATIONWIDE J-HOP NOCTURNAL BP STUDY
夜间家庭血压峰值是脑卒中早期且强烈的新危险因素：基于实践的全国J-HOP夜间血压研究

3. 研究名称：HOME BLOOD PRESSURE DURING NIGHT-TIME SLEEP AS A BETTER TREATMENT TARGET FOR PATIENTS WITH HYPERTENSOIN: A PROOF-OF-CONCEPT RANDOMIZED CONTROLLED TRIAL
夜间睡眠血压是高血压患者更好的治疗目标：概念验证随机对照试验

4.研究名称：ANTIHYPERTENSIVE TREATMENT OF MASKED HYPERTENSION GUIDED BY AMBULATORY BLOOD PRESSURE MONITORING: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
动态血压监测指导下隐匿性高血压的降压治疗：双盲安慰剂对照试验

5.研究名称：THE MEDICAL IMPACT OF EMERGENT BANNING OF N-NITROSODIMETHYLAMINE (NDMA)- CONTAMINATED ANTIHYPERTENSIVE DRUG: A NATIONWIDE LONGITUDINAL COHORT STUDY
紧急禁用N-亚硝基二甲胺（NDMA）污染降压药的医学影响：一项全国性的纵向队列研究

6.研究名称：EFFECT OF SEQUENTIAL NEPHRON BLOCKADE X DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE +BISOPROLOL IN THE TREATMENT OF RESISTANT HYPERTENSION, A RANDOMIZED CONTROLLED TRIAL (RESHYPOT)
序贯肾单位阻断与双肾素-血管紧张素系统阻滞剂+比索洛尔治疗难治性高血压的随机对照试验：RESHYPOT研究